Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing oral liquid for common cold (wind-heat syndrome)
CTR20190321Phase 3Suspended
- Sponsor
- Henan Xinyi Pharmaceutical
- Start
- Feb 2019
- Countries
- 1
01
Overview
A Phase 3 trial of tanreqing in nasopharyngitis, sponsored by Henan Xinyi Pharmaceutical. Started Feb 2019; status: suspended.
02
Drugs
tanreqing
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20190321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190321.